Unrealized potential of drug repositioning in europe during COVID-19 and beyond: a physcian's perspective

Journal of Pharmaceutical Policy and Practice
A B BayoumyC J J Mulder

Abstract

Drug repositioning is the scientific strategy of investigating existing drugs for additional clinical indications. The advantages of drug repositioning are that it benefits patients and that it adds new indications to existing drugs for lower costs compared to de novo drug development. Clinical research groups recognizing efficacy of these "old" drugs for a new indications often face an uphill struggle due to a lack of funding and support because of poor structural and regulatory support for clinical drug development. The current framework for drug repositioning allows "venture capital" companies to abuse loopholes in the legislation to gain long-term market authorization among with excessive high pricing. A new regulatory framework is needed to prevent abuse of the legislation and promote clinical investigator-driven drug repositioning. The COVID-19 pandemic has boosted funding and regulatory support for drug repositioning. The lessons learned from the COVID-19 pandemic should be implemented in a new clear blueprint for drug repositioning. This blueprint should guide clinicians through legislation for drug repositioning in the EU. This review summarizes the routes for registration and discusses the current state of drug reposi...Continue Reading

References

Dec 27, 1984·The New England Journal of Medicine·V M BerginerS Shefer
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·R J D'AmatoJ Folkman
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Donna WeberRaymond Alexanian
May 1, 1965·Clinical Pharmacology and Therapeutics·J SHESKIN
Sep 27, 2003·Leukemia·S KumarS V Rajkumar
Sep 3, 2009·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Rebecca Dresser, Joel Frader
Mar 13, 2010·Science·Takumi ItoHiroshi Handa
Apr 18, 2012·Archives of Internal Medicine·Tewodros EgualeRobyn Tamblyn
Aug 11, 2012·Mayo Clinic Proceedings·Christopher M WittichWilliam L Lanier
Oct 1, 2011·Therapeutic Advances in Hematology·Waqas RehmanHillard M Lazarus
May 16, 2014·Drug Development Research·Ashish Kumar Kakkar, Neha Dahiya
Jun 21, 2014·Journal of Gastrointestinal and Liver Diseases : JGLD·Chris J J MulderNanne K H de Boer
Nov 19, 2015·American Journal of Clinical Oncology·Michael G DanielMartin A Makary
Sep 5, 2017·Drug Discovery Today·Melek SimsekChris J J Mulder
Dec 8, 2017·Advances in Experimental Medicine and Biology·Antoni Montserrat Moliner, Jaroslaw Waligora
Jan 6, 2018·Orphanet Journal of Rare Diseases·Marc Dooms, Maria Carvalho
Jun 9, 2018·Nature Reviews. Drug Discovery·Alasdair Breckenridge, Robin Jacob
Jul 25, 2018·Lancet·Lucio LuzzattoUNKNOWN Second Workshop on Orphan Drugs participants
Jan 12, 2019·Orphanet Journal of Rare Diseases·Kavisha JayasundaraPaul Grootendorst
Mar 26, 2019·Alimentary Pharmacology & Therapeutics·Melek SimsekUNKNOWN Parelsnoer Institute (PSI), the Dutch Initiative on Crohn's and Colitis (ICC)
Jul 1, 2017·European Journal of Hospital Pharmacy. Science and Practice·H Pa ScheepersC Neef
Dec 22, 2019·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Aad VerripsAntonio Federico
Feb 25, 2020·Expert Opinion on Drug Metabolism & Toxicology·Ahmed B BayoumyNanne K De Boer
Mar 25, 2020·Nature Biotechnology·Charlotte Harrison
Apr 13, 2020·International Journal of Antimicrobial Agents·Marissa B SerafinRosmari Hörner
Apr 25, 2020·British Journal of Pharmacology·Cristina ScavoneAnnalisa Capuano
May 14, 2020·Journal of Experimental & Clinical Cancer Research : CR·Gennaro CilibertoMarco G Paggi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.